Purchases and Sales Made in Q4 2022 in Effector Therapeutics Inc (EFTRW)
This table provides information about the institutional ownership of Effector Therapeutics Inc (EFTRW) during Q4 2022. The information is specifically focused on institutions that hold shares of EFFECTOR THERAPEUTICS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
21KNew |
$1.05K - $5.68K
|
21K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Jefferies Financial Group Inc.
New York, NY |
BUY
|
- |
10KNew |
$500 - $2.7K
|
10K
$0
|
|
|
Sep 21, 2023
Q4 2022
|
Jefferies Financial Group Inc.
New York, NY |
BUY
|
- |
10KNew |
$500 - $2.7K
|
10K
$0
|
|
|
Feb 01, 2023
Q4 2022
|
Wolverine Asset Management LLC
|
BUY
|
- |
3.19K+ 25.82% |
$160 - $861
|
15.5K
$0
|
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Aristeia Capital LLC
Greenwich, CT |
SELL
|
- |
-17.2K- 1.1% |
$859 - $4.64K
|
1.54M
$0
|